The company is focused to provide stringent quality and compliance with all statutory requirements of WHO-GMP, environmental protection and safety.

To meet the oncoming challenges of the markets, the company has launched massive program for better across the globe representation including strategic alliances and concentrating on the domestic and export market with prime concerns.

Looking towards the future of the segment and growth in Pharma, the company brought the marketing arm-Oxalis Pharmaceuticals, with the product basket from various therapeutic segments, including Analgesics, Antipyretics, Anthelmintics, Anti-hypertensives, Anti-inflammatory preparations, Anti-bacterials, Cardiovascular drugs, Vitamins, Iron and protein tonics, etc. and with several products in the pipeline, this division is poised to further consolidate its position as a leading player in Ind